Author:
DiNardo C D,Daver N,Jain N,Pemmaraju N,Bueso-Ramos C,Yin C C,Pierce S,Jabbour E,Cortes J E,Kantarjian H M,Garcia-Manero G,Verstovsek S
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference14 articles.
1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th edn International Agency for Research on Cancer (IARC): Lyon, 2008.
2. Orazi A, Germing U . The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Leukemia 2008; 22: 1308–1319.
3. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937–951.
4. Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia 2006; 20: 1641–1644.
5. Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T et al. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia 2008; 22: 1295–1298.
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献